Ke, Jie – Trademark Portfolio

Entity Type: 01

Ke, Jie owns a portfolio of 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as CAXIKVEN, DFYOUHOME, and QZONELIFE. Of these, 3 are registered. The portfolio spans 4 Nice Classification classes, led by Class 25 (Clothing) and Class 8 (Hand Tools). Headquartered in Hubei.

Group 3, Xiafan Village,

Yanggang Town, Yangxin County,

Hubei 435211 , CN

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CAXIKVEN
CAXIKVEN
Registered 2023
DFYOUHOME
DFYOUHOME
Registered 2022
QZONELIFE
QZONELIFE
Registered 2022
VHOPE
VHOPE
Other 2020

Trademark Classifications

Ke, Jie's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (1 filing)

Clothing, footwear, headgear

8
Hand Tools (1 filing)

Hand tools and implements (hand-operated); cutlery; side arms; razors

17
Rubber Goods (1 filing)

Unprocessed and semi-processed rubber, gutta-percha, gum, asbestos, mica

23
Yarns & Threads (1 filing)

Yarns and threads, for textile use

Frequently Asked Questions

How many trademarks does Ke, Jie have?

Ke, Jie has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does Ke, Jie file in?

Ke, Jie files trademarks across 4 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 8 (Hand Tools), Class 17 (Rubber Goods), Class 23 (Yarns & Threads). Class 25 covers clothing, footwear, headgear.

What are Ke, Jie's most well-known trademarks?

Ke, Jie's registered trademark portfolio includes well-known marks such as CAXIKVEN, DFYOUHOME, and QZONELIFE. These are among 3 currently registered trademarks in the portfolio.

What is Ke, Jie's trademark registration success rate?

Ke, Jie has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.